Clinical Trial Update: Study of Tetrathiomolybdate in Patients With Wilson Disease [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial studying tetrathiomolybdate in Wilson disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Wilson Disease

Drugs mentioned

• Tetrathiomolybdate (tetrathiomolybdate)

Snippet

Sponsor: National Center for Research Resources (NCRR) | Conditions: Wilson Disease | Phase 3 | Status: COMPLETED